|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Other income (expenses), net | |||||
| Operating profit | |||||
| Interest income | |||||
| Other income | |||||
| Other gains and losses | |||||
| Finance costs | |||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method | |||||
| Profit before income tax | |||||
| Income tax expense | |||||
| Profit for the year | |||||
| Other comprehensive income (loss): | |||||
| Profit on remeasurements of defined benefit plans | |||||
| Unrealized (loss) gain on valuation of equity instruments at fair value through other comprehensive income | |||||
| Share of other comprehensive income of associates and joint ventures accounted for using equity method that will not be reclassified to profit or loss | |||||
| Income tax effect on components that will not be reclassified to profit or loss | |||||
| Components of other comprehensive (loss) income that will not be reclassified to profit or loss | |||||
| Exchange differences on translation of foreign operations | |||||
| Equity directly related to non-current assets held for sale | |||||
| Components of other comprehensive (loss) income that will be reclassified to profit or loss | |||||
| Other comprehensive (loss) income, net of income tax | |||||
| Total comprehensive income for the year | |||||
| Earnings per share - basic | |||||
| Ordinary shares [member] | |||||
| American depositary share (each representing 20 common shares) [member] | |||||
| Earnings per share - diluted | |||||
| Ordinary shares [member] | |||||
| American depositary share (each representing 20 common shares) [member] |
Loading...